valsartan has been researched along with Sensitivity and Specificity in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 15 (62.50) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fukami, T; Hosomi, H; Iwamura, A; Nakajima, M; Yokoi, T | 1 |
| Be Rziņš, KR; Fraser-Miller, SJ; Gordon, KC; Rades, T | 1 |
| Chung, DS; Foret, F; Řemínek, R | 1 |
| Chen, M; Cheng, X; Li, Y; Li, Z; Liu, Y; Mei, X; Xie, X; Yang, Y; Yu, F; Zhang, H; Zhou, J | 1 |
| Apola, A; Kwiecień, A; Maślanka, A; Opoka, W; Stolarczyk, M | 1 |
| Xu, C; Xu, J; Zhao, L | 1 |
| Cheng, WP; Lo, HM; Shyu, KG; Wang, BW | 1 |
| Chang, YM; Feng, CH; Lu, CY; Tseng, WL | 1 |
| Ezan, E; Levi, M; Pruvost, A; Wuerzner, G | 1 |
| Mullangi, R; Ramani, AV; Sengupta, P | 1 |
| Ayala, C; Clavijo, S; Contreras, Y; del Rosario Brunetto, M; Delgado, Y; Estela, JM; Gallignani, M; Martin, VC; Ovalles, F; Torres, D | 1 |
| Alonso, RM; Ferreirós, N; Gonzalez, O; Iriarte, G; Jiménez, RM; Maguregui, MI | 1 |
| Andraus, MH; Azevedo, CP; Borges, BC; Borges, NC; Moreira, RF; Moreno, RA; Salvadori, MC | 1 |
| Kothari, C; Mehta, P; Sharma, M; Sherikar, O | 1 |
| Klíma, J; Macek, J; Ptácek, P | 1 |
| Anavekar, NS; Arnold, JM; Bourgoun, M; Ghali, JK; Køber, L; Pfeffer, MA; Skali, H; Solomon, SD; Thune, JJ; Velazquez, EJ | 1 |
| Hara, H; Kawai, R; Kawashita, H; Koseki, N; Masuda, N; Nagae, Y; Niina, M; Tanaka, M | 1 |
| Gu, J; Jiang, Y; Li, H; Tang, Y; Wang, J; Wang, Y; Zhao, L | 1 |
| Humbert, H; Pommier, F; Prasad, P; Reynolds, CV; Sunkara, G; Yeh, C | 1 |
| Chen, K; Clark, SE; Ferrario, CM; Habibi, J; Sowers, JR; Stump, CS; Uptergrove, GM; Wei, Y; Whaley-Connell, AT | 1 |
| Du, X; Gu, J; Jiang, Y; Li, H; Liu, M; Zhang, D; Zhao, L | 1 |
| Davatz, A; Francotte, E; Richert, P | 1 |
| Beevers, DG; Beevers, M; Chung, NA; Lip, GY | 1 |
| Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Wiesner, K | 1 |
3 trial(s) available for valsartan and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous determination of losartan and hydrochlorothiazide in human plasma by LC/MS/MS with electrospray ionization and its application to pharmacokinetics.
Topics: Administration, Oral; Adult; Chlorthalidone; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Humans; Hydrochlorothiazide; Losartan; Male; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tetrazoles; Therapeutic Equivalency; Valine; Valsartan | 2009 |
Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
Topics: Adult; Antihypertensive Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Hypolipidemic Agents; Male; Probability; Reference Values; Risk Factors; Sensitivity and Specificity; Simvastatin; Single-Blind Method; Tetrazoles; Time Factors; Valine; Valsartan | 2007 |
ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hypertension, Renovascular; Male; Middle Aged; Radioisotope Renography; Radiopharmaceuticals; Renal Artery Obstruction; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Mertiatide; Tetrazoles; Valine; Valsartan | 2002 |
21 other study(ies) available for valsartan and Sensitivity and Specificity
| Article | Year |
|---|---|
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.
Topics: Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Benzbromarone; Biotransformation; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; HEK293 Cells; Hep G2 Cells; Hepatocytes; Humans; Losartan; NF-E2-Related Factor 2; Semicarbazides; Sensitivity and Specificity; Time Factors; Uricosuric Agents | 2011 |
Low-Frequency Raman Spectroscopy as an Avenue to Determine the Transition Temperature of β- and γ-Relaxation in Pharmaceutical Glasses.
Topics: Calorimetry, Differential Scanning; Celecoxib; Cimetidine; Indoles; Pharmaceutical Preparations; Phenylcarbamates; Sensitivity and Specificity; Spectrum Analysis, Raman; Sulfonamides; Temperature; Transition Temperature; Valsartan | 2022 |
Application of capillary electrophoresis-nano-electrospray ionization-mass spectrometry for the determination of N-nitrosodimethylamine in pharmaceuticals.
Topics: Dimethylnitrosamine; Drug Contamination; Electrophoresis, Capillary; Linear Models; Nanotechnology; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tablets; Valsartan | 2021 |
Simultaneous determination of metolazone and valsartan in plasma by on-line SPE coupled with liquid chromatography/tandem mass spectrometry.
Topics: Animals; Chromatography, Liquid; Dogs; Linear Models; Male; Metolazone; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Valsartan | 2017 |
Spectrophotometric method for simultaneous determination of valsartan and substances from the group of statins in binary mixtures.
Topics: Atorvastatin; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Pravastatin; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry; Valsartan | 2017 |
Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.
Topics: Aged; Antihypertensive Agents; Autoantibodies; Biomarkers; Diabetes Mellitus, Type 2; Dilatation, Pathologic; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Metoprolol; Middle Aged; Predictive Value of Tests; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-1; Risk Factors; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan | 2014 |
MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction.
Topics: Animals; Atorvastatin; Blotting, Western; Cells, Cultured; Disease Models, Animal; Endoglin; Fibrosis; Gene Expression Regulation; Hemodynamics; Heptanoic Acids; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Muscle Cells; Myocardial Infarction; Polymerase Chain Reaction; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2015 |
Analysis of angiotensin II receptor antagonist and protein markers at microliter level plasma by LC-MS/MS.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biomarkers; Blood Proteins; Chromatography, Liquid; Drug Monitoring; Humans; Molecular Structure; Nanotechnology; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles; Valine; Valsartan | 2009 |
Direct analysis of valsartan or candesartan in human plasma and urines by on-line solid phase extraction coupled to electrospray tandem mass spectrometry.
Topics: Benzimidazoles; Biphenyl Compounds; Humans; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tetrazoles; Valine; Valsartan | 2009 |
Development and validation of a highly sensitive and robust LC-ESI-MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical pharmacokinetic study.
Topics: Acetonitriles; Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Simvastatin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tetrazoles; Time Factors; Valine; Valsartan | 2009 |
Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Chromatography, High Pressure Liquid; Humans; Losartan; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Validation of a fast liquid chromatography-UV method for the analysis of drugs used in combined cardiovascular therapy in human plasma.
Topics: Cardiovascular Agents; Chlorthalidone; Chromatography, Liquid; Drug Stability; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tetrazoles; Time Factors; Valine; Valsartan | 2009 |
Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Combinations; Hydrochlorothiazide; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets; Tetrazoles; Valine; Valsartan | 2014 |
Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography.
Topics: Angiotensin Receptor Antagonists; Blood Proteins; Calibration; Chemical Precipitation; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan | 2006 |
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study.
Topics: Aged; Antihypertensive Agents; Comorbidity; Echocardiography; Female; Heart Failure; Humans; Internationality; Male; Middle Aged; Myocardial Infarction; Prevalence; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2006 |
Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Antihypertensive Agents; Chromatography, Liquid; Drug Stability; Humans; Molecular Structure; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Temperature; Tetrazoles; Valine; Valsartan | 2007 |
A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles; Valine; Valsartan | 2007 |
NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Blood Pressure; Blotting, Western; C-Reactive Protein; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Insulin Resistance; Male; Muscle, Smooth, Vascular; NADPH Oxidases; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sensitivity and Specificity; Superoxide Dismutase; Tetrazoles; Valine; Valsartan; Vasculitis | 2007 |
Determination of ecabet in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Topics: Abietanes; Area Under Curve; Chromatography, High Pressure Liquid; Humans; Hydrophobic and Hydrophilic Interactions; Methanol; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tetrazoles; Valine; Valsartan | 2008 |
Development and validation of chiral high-performance liquid chromatographic methods for the quantitation of valsartan and of the tosylate of valinebenzyl ester.
Topics: Antihypertensive Agents; Chromatography, High Pressure Liquid; Esters; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Tetrazoles; Tosyl Compounds; Valine; Valsartan | 1996 |
Angiotensin-II-receptor inhibitors in pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prenatal Care; Risk Assessment; Sensitivity and Specificity; Tetrazoles; Time Factors; Valine; Valsartan | 2001 |